Advertisement

Diabetes Therapy

, Volume 8, Issue 5, pp 963–965 | Cite as

Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes

  • Fernando Gomez-PeraltaEmail author
  • Cristina Abreu
  • Albert Lecube
  • Diego Bellido
  • Alfonso Soto
  • Cristóbal Morales
  • Miguel Brito-Sanfiel
  • Guillermo Umpierrez
Open Access
Erratum
  • 656 Downloads
Part of the following topical collections:
  1. Practical Approaches

Erratum to: Diabetes Ther DOI 10.1007/s13300-017-0277-0

In the original publication, corresponding author e-mail address and Fig. 2 were published incorrectly. The correct e-mail address and the revised Fig. 2 are given here.
Fig. 2

Proposed algorithm for adjusting antidiabetic agents (a) and diuretic/antihypertensive therapy (b) when initiating SGLT2 inhibitors in patients with type 2 diabetes. DPP4i DPP4 inhibitors, GI gastrointestinal, GLP1ra GLP-1 receptor agonists, SU sulfonylureas, SMBG self-monitoring of blood glucose, BP blood pressure. *Avoid insulin withdrawal to minimize the risk of euglycemic diabetic ketoacidosis. **Hemodynamically unstable defined as atrial fibrillation, orthostatic hypotension or blood pressure lability, prior syncope, etc. ***Clinical situation defined by congestive heart failure, edema, renal function

The corresponding author’s e-mail address should read as fgomezp@saludcastillayleon.es.

The incorrect statement in Fig. 2 “BP <140/80 mmHg, aged older than 65 years or hemodynamically unstable*?” should read as “BP <140/80 mmHg, aged older than 65 years or hemodynamically unstable**?”

The incorrect statement in Fig. 2 “Reintroduce treatment according to clinical situation**?” should read as “Reintroduce treatment according to clinical situation***?”

Notes

Open Access

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright information

© The Author(s) 2017

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Fernando Gomez-Peralta
    • 1
    Email author
  • Cristina Abreu
    • 1
  • Albert Lecube
    • 2
  • Diego Bellido
    • 3
  • Alfonso Soto
    • 4
  • Cristóbal Morales
    • 5
  • Miguel Brito-Sanfiel
    • 6
  • Guillermo Umpierrez
    • 7
  1. 1.Endocrinology and Nutrition UnitSegovia General HospitalSegoviaSpain
  2. 2.Endocrinology and Nutrition Unit, Hospital Universitari Arnau de Vilanova de Lleida, Institut de Recerca Biomèdica de Lleida, CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas, ISCIII)University of LleidaLleidaSpain
  3. 3.Endocrinology and Nutrition SectionHospital MarcideFerrolSpain
  4. 4.Endocrinology and Nutrition DepartmentHospital de La CoruñaA CoruñaSpain
  5. 5.Endocrinology and Nutrition DepartmentVirgen Macarena HospitalSevilleSpain
  6. 6.Endocrinology and Nutrition DepartmentHospital Universitario Puerta de Hierro MajadahondaMadridSpain
  7. 7.Department of MedicineEmory University School of MedicineAtlantaUSA

Personalised recommendations